Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology|December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorderLana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Annals of Neurology|July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology|April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined SynucleinopathyDaniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Brain Communications|March 21, 2025
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationLana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein AggregatesLana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Brain : a Journal of Neurology|May 26, 2026
Is SORL1 a common genetic target across neurodegenerative diseases? A multi-ancestry biobank studyMarzieh Khani, Sheila N Yeboah, Catalina Cerquera-Cleves, et al.
Pageof 5